both 2.5 % and 10 % phenylephrine have been associated with cardiovascular effects and should be used with caution in selected patients on monoamine oxidase inhibitors , tricyclic antidepressants or atropine or in those with hypertension , advanced arteriosclerotic changes , aneurysms , orthostatic hypotension , long-standing insulin-dependent diabetes and in children with low bodyweights .
C0031469
phenylephrine
C0020538
hypertension